Marked reduction of the alpha-fetoprotein levels among individuals with chronic hepatitis C, following Peg-interferon and ribavirin treatment

被引：1
|
作者：
Aladag, M [1 ]
Camci, C [1 ]
Huang, Y [1 ]
Wright, H [1 ]
Rizvi, S [1 ]
Gurakar, A [1 ]
Stokes, K [1 ]
Sebastian, A [1 ]
机构：
[1] Integris Baptist Med Ctr, Nazih Zuhdi Transplantat Inst, Div Liver Transplantat Med Hepatol, Oklahoma City, OK 73112 USA
来源：
JOURNAL OF CLINICAL GASTROENTEROLOGY | 2005年 / 39卷 / 10期
关键词：
D O I：
10.1097/01.mcg.0000180801.64575.4f
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：923 / 924
页数：2
相关论文
共 50 条
  • [1] The effect of statins on PEG-interferon/ribavirin treatment for chronic hepatitis C
    Yen, Roy D.
    Prabhu, Anoop
    Mahl, Thomas
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2007, 102 : S217 - S217
  • [2] Treatment with PEG-interferon and ribavirin therapy in dialysis patients with chronic hepatitis C
    Tan, Adriaan C.
    de Vries, Richard A.
    Adang, Rob
    Konings, Stijn
    Cnossen, Nynke
    Schalm, Solko W.
    van Leusen, Rob
    HEPATOLOGY, 2006, 44 (04) : 321A - 321A
  • [3] THERAPEUTIC RESPONSE TO PEG-INTERFERON PLUS RIBAVIRIN IN CHRONIC HEPATITIS C
    Harja-Alexa, Ioana-Alina
    Luca, Mihaela-Catalina
    Manciuc, Carmen Doina
    Vata, A.
    Badescu, Aida
    Hurmuzache, M. E.
    Ciocan, Alexandra Mirela
    Hunea, Ioana Maria
    Trofin, Felicia
    Iancu, Luminita Smaranda
    MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2019, 123 (04): : 615 - 622
  • [4] Reversible alopecia universalis during treatment with PEG-interferon and ribavirin for chronic hepatitis C
    Taliani, G
    Biliotti, E
    Capanni, M
    Tozzi, A
    Bresci, S
    Pimpinelli, N
    JOURNAL OF CHEMOTHERAPY, 2005, 17 (02) : 212 - 214
  • [5] Treatment with PEG-interferon and Ribavirin for Chronic Hepatitis C Increases Neutrophil and Monocyte Chemotaxis
    Giorgini, Alessia
    Capsoni, Franco
    Podda, Mauro
    Lleo, Ana
    Battezzati, Pier Maria
    Ongari, Anna Maria
    Selmi, Carlo
    Benetti, Alberto
    Malinverno, Federica
    Rossaro, Lorenzo
    Gershwin, M. Eric
    Zuin, Massimo
    CONTEMPORARY CHALLENGES IN AUTOIMMUNITY, 2009, 1173 : 847 - 857
  • [6] Effects of PEG-interferon alpha plus ribavirin on tryptophan metabolism in patients with chronic hepatitis C
    Comai, Stefano
    Cavalletto, Luisa
    Chemello, Liliana
    Bernardinello, Elisabetta
    Ragazzi, Eugenio
    Costa, Carlo Virgilio Luigi
    Bertazzo, Antonella
    PHARMACOLOGICAL RESEARCH, 2011, 63 (01) : 85 - 92
  • [7] Treatment with PEG-interferon and ribavirin for chronic hepatitis C does not decrease neutrophil and monocyte activity
    Giorgini, A.
    Capsoni, F.
    Lleo, A.
    Selmi, C.
    Ongari, A. M.
    Benetti, A.
    Ferrari, B.
    Invernizzi, P.
    Podda, M.
    Zuin, M.
    JOURNAL OF HEPATOLOGY, 2006, 44 : S198 - S198
  • [8] PEG-Interferon alfa2b plus ribavirin treatment in chronic hepatitis C
    Müller, T
    MONATSSCHRIFT KINDERHEILKUNDE, 2005, 153 (12) : 1192 - 1192
  • [9] The effect of interferon therapy on alpha-fetoprotein levels in patients with chronic hepatitis C.
    Gochu, J
    Mirza, A
    Kaur, S
    Ganger, D
    Rosenblate, H
    Jensen, D
    HEPATOLOGY, 1996, 24 (04) : 1084 - 1084
  • [10] Aplastic anemia and severe pancytopenia during treatment with peg-interferon, ribavirin and telaprevir for chronic hepatitis C
    Lens, Sabela
    Calleja, Jose L.
    Campillo, Ana
    Carrion, Jose A.
    Broquetas, Teresa
    Perello, Christie
    de la Revilla, Juan
    Marino, Zoe
    Londono, Maria-Carlota
    Sanchez-Tapias, Jose M.
    Urbano-Ispizua, Alvaro
    Forns, Xavier
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (17) : 5421 - 5426
12345